SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Dell Technologies, Inc. is a technology company, providing customers with a broad and innovative solution portfolio to help customers modernize their information technology (IT) infrastructure, address workforce transformation, and offer critical solutions that keep people and organizations connected. It operates through the following segments: Infrastructure Solutions Group (ISG) and Client Solutions Group (CSG). The ISG segment includes servers, networking, and storage, as well as services and third-party software and peripherals that are closely tied to the sale of ISG hardware. The CSG segment includes designs for commercial and consumer customers of desktops, thin client products, and notebooks. The company was founded by Michael Saul Dell in 1984 and is headquartered in Round Rock, TX.

Dell Technologies Inc - Ordinary Shares - Class C

Dell Technologies Inc

Dell Technologies shares surged following record quarterly results that easily topped analyst expectations, fueled by explosive growth in AI server demand and a massive increase in the company's full-year financial outlook. While the stock initially saw volatility, the community sentiment remains overwhelmingly bullish as traders look to the significant AI server backlog as a primary driver of long-term value.

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

QQQ is trending lower as investors weigh escalating geopolitical tensions in the Middle East against concerns that higher oil prices and rising Treasury yields will pressure the Federal Reserve to maintain a hawkish stance. While some retail traders are betting on a recovery, sentiment is dampened by the potential for interest rate hikes and broader macroeconomic headwinds.

United States Oil Fund LP - United States Oil Fund

United States Oil Fund

USO is trending following resumed military strikes between the U.S. and Iran near the Strait of Hormuz, which traders believe will disrupt global oil supplies and keep energy prices elevated. The community is sharply divided between those positioning for further gains on supply fears and those expecting a price correction amid skepticism over ongoing geopolitical tensions.

SPDR S&P 500 ETF TRUST - SPDR S&P 500 ETF Trust

The S&P 500 is trending lower as investors weigh escalating geopolitical tensions in the Middle East against a resilient AI-driven corporate earnings season. Rising oil prices and climbing U.S. Treasury yields have fueled market concerns over potential interest rate hikes, leading to widespread debate among traders about the sustainability of equity valuations.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bull 3X ETF

Direxion Daily Semiconductor Bull 3X Shares

Semiconductor shares are experiencing significant volatility as investors weigh robust earnings from industry leaders like Nvidia against broader macroeconomic concerns, including rising bond yields and geopolitical tensions. Market participants remain divided on the long-term sustainability of AI-driven capital expenditure, leading to a tug-of-war between bullish sentiment around chip growth and bearish reactions to inflationary pressures.

Oklo, Inc. engages in the development of fission reactors. It provides clean energy through the design and deployment of fast fission power plants. The company was founded by Jacob DeWitte and Caroline Cochran on July 3, 2013 and is headquartered in Santa Clara, CA.

Oklo Inc. - Ordinary Shares - Class A

Oklo Inc.

Oklo is trending primarily due to ongoing volatility and heavy short interest, with the community polarized between traders expecting a major short squeeze and those criticizing the company for a lack of commercial revenue and frequent insider share sales. While some investors point to potential long-term catalysts like nuclear fuel fabrication developments and data center demand, others remain focused on the stock's steady decline toward 52-week lows.

Sovereign frontier cloud for AI that builds  AI agents are starting to build and operate real software. Agentic organizations are starting to coordinate people, code, data, payments, and governance. Both need a cloud that is sovereign, tamperproof, and always on.  The Internet Computer is that cloud.  Built on more than USD 500 million in R&amp;D, ICP uses advanced blockchain technology and cryptography to run entire software systems end-to-end on the network: websites, apps, services, data, payments, and governance. Code and data are protected by the protocol, replicated across independent nodes, and cannot be silently changed by a cloud provider, backend operator, or attacker.  Cloud engines make this infrastructure sovereign. They let organizations run ICP-powered compute across chosen providers, locations, and jurisdictions while keeping the same tamperproof and always-on guarantees of the network.  This is the real demand ICP serves: sovereign frontier cloud for AI agents and agentic organizations. Agents can build and update software. Organizations can run rules, assets, and governance as verifiable systems. The result is software that stays online, keeps its data, and remains under the control of its owners.  Developers and AI agents can build on the Internet Computer with any AI assistant using the ICP skill library at skills.internetcomputer.org, or by creating apps through conversation with Caffeine AI.  Computation on ICP is paid for by converting $ICP into cycles. $ICP is also used for staking and governance through the Network Nervous System.

Internet Computer

Investors are expressing strong conviction in ICP as decentralized infrastructure, specifically highlighting its utility for AI-native applications and sovereign cloud solutions as a superior alternative to centralized providers. While market sentiment remains mixed due to historical price performance, bullish participants emphasize the importance of long-term staking, ecosystem development like Cloud Engines, and potential enterprise or government adoption as key catalysts for future value.

SoFi Technologies, Inc. is a financial service platform, which engages in the provision of student loan refinancing options to the private student loan market. It operates through the following segments: Lending, Technology Platform, and Financial Services. The Lending segment offers personal loans, student loans, home loan products, and related servicing activities. The Technology Platform segment focuses on technology products and solutions revenue. The Financial Services segment includes the SoFi Money product, SoFi Invest product, SoFi Credit Card product, SoFi Relay personal finance management product, and other financial services. The company was founded in April 2011 and is headquartered in San Francisco, CA.

SoFi Technologies Inc

SoFi is facing downward pressure amid broader fintech weakness and investor frustration over the stock's persistent lack of upward momentum. Traders are debating whether the recent decline offers a long-term entry point or if the company's valuation remains tethered to macro headwinds and institutional sentiment.

Palo Alto Networks, Inc. engages in the provision of network security solutions to enterprises, service providers, and government entities. It operates through the following geographical segments: the United States, Israel, and Other Countries. The company was founded by Nir Zuk in March 2005 and is headquartered in Santa Clara, CA.

Palo Alto Networks Inc

Palo Alto Networks is trending as traders analyze the company's fiscal fourth-quarter results, which featured earnings and revenue beats, alongside an upbeat fiscal 2027 outlook and the acquisition of AI-native platform Console. While the community reaction is polarized between bullish long-term sentiment regarding AI-driven cybersecurity tailwinds and bearish concerns over high valuation multiples and slowing organic growth metrics.

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products include diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly on May 10, 1876 and is headquartered in Indianapolis, IN.

Lilly(Eli) & Co

Eli Lilly is trending as investors rotate into the healthcare sector ahead of anticipated earnings, with strong demand for its GLP-1 obesity and diabetes medications fueling expectations for a major breakout. Community sentiment remains bullish, with the stock viewed as a long-term compounder that is effectively capturing market share through a robust pipeline and manufacturing expansion.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

OmniAb to Participate in Upcoming Investor Conferences

OmniAb, Inc. (NASDAQ: OABI), a provider of cutting-edge discovery research technology to enable the discovery of next-generation therapeutics, today announced managements participation in the following upcoming investor conferences: Nasdaq/LD Micro Summit Series Date: Wednesday, September 9, 2026...

The Nasdaq Stories Traders Can't Ignore

Here are today’s catalysts that are changing the narrative. $NTHI, $IPST, $OABI, $LLY, $HIVE, and $IVF

Why Is Omniab Stock Rallying After Eli Lilly Deal?

The OmniAb Lilly Deal offers up to $370 million in milestones as OABI raises its 2026 cash outlook and shares jump premarketread more...

OmniAb Lands Lilly and Raises Guidance: $370M Deal Puts OABI’s Discovery Platform in the Spotlight

OmniAb (NASDAQ:OABI) may be one of the more interesting picks-and-shovels stories emerging in biotech, and its latest deal with Eli Lilly & Company (NYSE:LLY) could be another indication that the pharmaceutical industry sees value in the company’s technology rather than simply another early-stage drug program.

OmniAb Raises 2026 Financial Guidance

OmniAb, Inc. (NASDAQ: OABI), a provider of cutting-edge discovery research technology to enable the discovery of next-generation therapeutics, today raised its 2026 cash and cash equivalents financial guidance following recent technology licensing activity. Recent business development and licensing...

OmniAb Announces Global Collaboration and License Agreement for Ion Channel Program with Eli Lilly & Company

OmniAb, Inc. (NASDAQ: OABI), a provider of cutting-edge discovery research technology to enable the discovery of next-generation therapeutics, today announced a global collaboration and license agreement with Eli Lilly and Company (Lilly) for a new ion channel program. The collaboration leverages...

OmniAb (OABI) Q2 2026 Earnings Call Transcript

@media (max-width: 768px) {
 .image-container {
 width: 100% !important;
 float: none !important;
 margin: 0 0 1rem 0 !important;
 }
 }

Image source: The Mo...

OmniAb, Inc. (OABI) Reports Q2 Loss, Beats Revenue Estimates

OmniAb, Inc. (OABI) delivered earnings and revenue surprises of +54.55% and +149.67%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

OmniAb Reports Second Quarter 2026 Financial Results and Business Highlights

OmniAb, Inc. (NASDAQ: OABI), a provider of cutting-edge discovery research technology to enable the discovery of next-generation therapeutics, today reported financial results for the three and six months ended June 30, 2026, provided operating and partner program progress, and updated 2026...

OmniAb to Report Second Quarter 2026 Financial Results on August 6

OmniAb, Inc. (NASDAQ: OABI), a provider of cutting-edge discovery research technology to enable the discovery of next-generation therapeutics, today announced the Company will report financial results for the three and six months ended June 30, 2026, after the close of the U.S. financial markets on...

• Reported GAAP EPS of -$0.05 up 66.67% YoY
• Reported revenue of $13.41M up 244.24% YoY
• OmniAb updated its 2026 financial guidance, now expecting revenue in the range of $32 million to $36 million and cash costs and operating expenses between $51 million and $55 million.

OmniAb faced a non-cash impairment from discontinued programs, a year-over-year increase in other operating expenses, and ongoing structural risks related to reliance on partner-led drug development and commercialization efforts.

OmniAb achieved significant year-over-year revenue growth driven by milestone payments, while expanding its active partner and program counts and advancing key partner-led therapeutic candidates into late-stage clinical trials.

OmniAb, Inc. operates as a drug discovery company. The firm focuses on developing human monoclonal and bispecific therapeutic antibodies. Its platform includes the biological intelligence of its transgenic animals, including OmniRat, OmniChicken and OmniMouse. The company was founded on December 14, 2015 and is headquartered in Emeryville, CA.

OmniAb Inc

Bearish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$4.44
Prev Close	$4.38
Open	$4.35
Dividend Yield	0.00%
50-Day Moving Average	$2.86
Beta	1.09
Avg. Volume	2.23M
PE Ratio	-12.31

52-Week High	$4.93
52-Week Low	$1.30
Market Capitalization	$636.81M
EPS (Annual)	-$0.5701
Price to Book	2.48
Revenue Per Employee	$209,730.34

Feed

News

Sentiment

Earnings

Fundamentals

Info